TO-207

N/A

Report date: 2026/02/03 16:05:55
NME

Base Information

Drug NameTO-207
Drug Alias NameJTE-607TO-207
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCytokine production inhibitorsCleavage and polyadenylation specificity factor subunit 3 inhibitors
TargetsCytokinesCleavage and polyadenylation specificity factor subunit 3
Therapy Area/IndicationsCytokine Release SyndromeSystemic Inflammatory Response Syndrome
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryJapan
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesJapan Tobacco (Hong Kong) Ltd
China Registration ClassN/A

Develop Information

Active CompaniesTorii Pharmaceutical Co Ltd
Inactive CompaniesJapan Tobacco (Hong Kong) Ltd
Active IndicationsCytokine Release Syndrome
Inactive IndicationsSystemic Inflammatory Response Syndrome

Other Information

ATC CodeN/A
Related LinksN/A